Oklahoma Heart Transplant Survivor Returns Home After 726 Days in Hospital

Fable, a young patient at OU Children's Hospital, finally gets to go home after over 2 years of treatment.

Published on Feb. 9, 2026

Got story updates? Submit your updates here. ›

Fable, a young patient at OU Children's Hospital in Oklahoma City, has been able to return home for the first time after spending 726 days - over 2 years - in the hospital. Fable was diagnosed before birth with a rare and complex heart defect and underwent a heart transplant as part of her treatment.

Why it matters

Fable's story highlights the incredible challenges and perseverance required for children with severe congenital heart defects to receive the care they need. Her long hospital stay underscores the dedication of the medical team at OU Children's Hospital and the resilience of pediatric heart transplant patients.

The details

Fable was diagnosed with her heart condition before birth and spent over 2 years receiving treatment at OU Children's Hospital, including undergoing a heart transplant. After her extended hospital stay, Fable was finally able to return home, marking a major milestone in her recovery.

  • Fable was diagnosed with a rare heart defect before birth.
  • Fable spent 726 days - over 2 years - receiving treatment at OU Children's Hospital.
  • Fable was finally able to return home in February 2026.

The players

Fable

A young patient at OU Children's Hospital who was diagnosed with a rare and complex heart defect before birth and spent over 2 years receiving treatment, including a heart transplant, before being able to return home.

OU Children's Hospital

The Oklahoma City hospital that provided Fable with the extensive care and treatment she needed over her 726-day hospital stay.

Got photos? Submit your photos here. ›

The takeaway

Fable's remarkable journey home after over 2 years in the hospital underscores the incredible advances in pediatric heart care and the dedication of medical teams in providing life-saving treatment for children with complex congenital heart defects.